Volume 4, Issue 10 | October 2026
|
|
|
|
|
|
|
|
|
|
|
|
Connect with our Business Development team to explore licensing, collaboration and commercialization opportunities.
|
Top Mayo Clinic headlines
|
|
|
|
|
|
|
Business Development’s impact in focus: Eight years of innovation at Mayo Clinic
Economic Club of Minnesota
In a recent address to the Economic Club of Minnesota, Mayo Clinic President and CEO Gianrico Farrugia, MD, reflected on major accomplishments that have shaped Mayo Clinic during his tenure, including several where Mayo Clinic Business Development played a key role. From incubating Mayo Clinic Platform and digital pathology to advancing AI-enabled ECGs, StateViewer and Precure, and helping establish the Microsoft partnership, the presentation offers a powerful look at how this work has helped turn bold ideas into solutions with the potential to transform patient care.
Watch the presentation.
|
|
|
|
|
|
|
Rochester’s biomedical economy is growing, and so is its need for talent
MPR News
As Rochester’s bioscience ecosystem expands around Mayo Clinic, startups are creating new opportunities and demand for specialized talent. Mayo Clinic spin-offs Cytotheryx and Vyriad illustrate both the advantages of building companies near Mayo Clinic’s clinical and research expertise and the challenge of recruiting the diverse scientific, business and leadership talent needed to fuel continued growth. Read more...
|
|
|
|
|
|
|
Penske Foundation gift supports transformation of the patient arrival experience
PR Newswire
The new Penske Arrival Building will bring transportation, navigation, hospitality and personal support together in a welcoming gateway to Mayo Clinic’s downtown Rochester campus. Part of the $10 billion Bold. Forward. Unbound. investment, the space is designed to make arriving and departing easier so patients and families can focus on what matters most: their care. Read more...
|
|
|
|
|
|
Portfolio company and collaboration updates
|
|
|
|
|
|
|
|
|
Mayo Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear
The new company will build one of the world’s leading biomedical datasets, integrating genomic, proteomic and longitudinal clinical data from one million biospecimens. Using AI and advanced analytics, the effort aims to uncover the earliest biological signals of disease and accelerate new opportunities for prevention, diagnosis and treatment. Read more...
➜ Also announced: Precure selects Helix as lab and AI tools provider
|
|
|
|
|
|
Renew Biotechnologies to evaluate NeuroLens in MS and related diseases
|
|
|
|
|
|
Vyriad begins Phase 1 trial of in vivo CAR T-cell therapy
|
|
|
|
|
|
Mayo Clinic and Nemours collaborate to advance pediatric innovation
|
|
|
|
|
|
Trusted Health brings CareCast workforce forecasting to health systems
|
|
|
|
|
|
|
|
|
|
Mayo Clinic research advancements
|
|
|
|
|
|
Building ethical AI for better patient care
Mayo Clinic Magazine
Sonya Makhni, MD, MS, is helping develop AI systems that clinicians can understand and trust, with safeguards to monitor accuracy, reduce bias and protect health equity. Her work includes Synapse, a clinical decision support tool designed to connect complex patient information and surface more personalized insights at the point of care. Read more...
|
|
|
|
|
Blood test detects 17 cancer types in large prospective study
|
|
|
|
Five distinct subtypes of common liver disease identified
|
|
|
|
AI analysis may help predict pancreatic cancer recurrence
|
|
|
|
|
|
|
Immune cell discovery could improve glioblastoma treatment
|
|
|
|
Reprogramming thyroid tumors may improve CAR-T cell therapy
|
|
|
|
New radiosurgery approach reduces brain metastasis recurrence
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BioLabs is currently accepting applications for their first golden ticket to the BioLabs Rochester space. The selected applicant wins complimentary lab space (paid for by BioLabs), mentorship and more.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
About Business Development
|
Business Development is Mayo Clinic’s front door to business – from technology commercialization to strategic collaborations – catalyzing innovation to shape the future of healthcare for the benefit of patients.
The department bridges the gaps between industry and commercial groups to produce meaningful, effective changes in transforming health and medicine.
|
|
|
|
|
|
|
|
|
